Increased body weight associated with prolactin secreting pituitary adenomas: Weight loss with normalization of prolactin levels

Clinical Endocrinology

Volumn 48, Issue 5, 1998, Pages 547-553

  Greenman, Yona ^a   Tordjman, Karen ^a   Stern, Naftali ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ARTICLE; BODY WEIGHT; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPOPHYSIS ADENOMA; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TUMOR VOLUME; WEIGHT REDUCTION;

ADULT; BROMOCRIPTINE; FEMALE; HORMONE ANTAGONISTS; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 0031800686     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00403.x     Document Type: Article

References (24)

1. Amatruda, J.M. & Welle, S. (1995) Obesity, In: Endocrinology and Metabolism (eds. P. Felig, J.D. Baxter & L.A. Frohman) New York: McGraw-Hill Inc.; pp. 1271-1313.
2. Argenio, G.F., Bernini, G.P., Del Corso, C., Santoni, R. & Franchi, F. (1991) Naloxone does not modify fenfluramine induced prolactin increase in obese patients. Clinical Endocrinology, 35, 505-508.
3. Bemini, G.P., Argenio, G.F., Vivaldi, M.S., Del Corso, C., Sgro, M., Franchi, F. & Luisi, M. (1989) Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system. Hormone Research, 31, 33-37.
4. Cincotta, A.M. & Meier, A.H. (1996) Bromocriptine (Ergoset) reduces hody weight and improves glucose tolerance in ohese subjects. Diabetes Care, 19, 667-670.
5. Creemers, L.B., Zelissen, P.M.J., van't Vorlaut, J.W. & Koppeschaar, H.P.F. (1991) Prolactinoma and body weight: a retrospective study. Acta Endocrinologica (Copenh), 125, 392-396.
6. Cuneo, R.C., Salomon, F., McGauley, G.A & Sönksen, P.H. (1992) The growth hormone deticiency syndrome in adults. Clinical Endocrinology, 37, 387-397.
7. Donders, S.H., Pieters, G.F., Heevel, J.G., Ross, H.A., Smals, A.G. & Kloppenborg, P.W. (1985) Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity. Journal of Clinical Endocrinology and Metabolism, 61, 56-59.
8. Ferreira, M.F., Sohrinho, L.G., Pires, J.S., Silva, M.E.S., Santos, M.A. & Sousa, M.F.F. (1995) Endocrine and psychological evaluation of women with recent weight gain. Psychoneuroendocrinology, 20, 53-63.
9. Greenman, Y., Tordjman, K., Kisch, E., Razon, N., Ouaknine, G. & Stern, N. (1995) Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. Journal of Clinical Endocrinology and Metabolism, 80, 1577-1583.
10. Hansen, T.B., Vahl, N., Jorgensen, J.O.L., Christiansen, J.S. & Hagen, C. (1995) Whole body and regional soft tissue changes in growth hormone deficient adults over one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study. Clinical Endocrinology, 43, 689-696.
11. Howlett, T.A. (1997) An assessment of optimal hydrocortisone replacement therapy. Clinical Endocrinology, 46, 263-268.
12. Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jorgensen, L., Ingemann-Hansen, T., Skakkebaek, N.B. & Christiansen, J.S. (1989) Beneficial effects on growth hormone treatment in GH-deficient adults. Lancet, i, 1221-1225.
13. Lachelin, G.C.L., Abu-Fadil, S. & Yen, S.S.C. (1997) Functional delineation of hyperprolactinaemic-amenorrhea. Journal of Clinical Endocrinology and Metabolism 44, 1163-1174.
14. Monson, J.P. (1997) The assessment of glucocorticoid replacement therapy. Clinical Endocrinology, 46, 169-270.
15. Noel, M.B. & Woodside, B. (1993) Effects of systemic and central prolactin injections on food intake, weight gain and estrous cyclicity in female rats. Physiology and Behavior, 54, 151-154.
16. Nunes, M.C.P., Sobrinho, L.G., Calhaz-Jorge, C., Santos, M.A., Mauricio, J.C. & Sousa, M.F. (1980) Psychosomatic factors in patients with hyperprolactinaemia and/or galactorhea. Obstetrics and Gynecology, 55, 591-595.
17. Peacey, S.R., Guo, C.Y., Robinson, A.M., Price, A., Giles, M.A., Eastell, R. & Weetman, A.P. (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology, 46, 255-261.
18. Pijl, H., Koppeschaar, H.P., Willekens, F.L., Frolich, M. & Meinders, A.E. (1993) The influence of serotoninergic neurotransmission on pituitary hormone release in obese and non-obese females. Acta Endocrinologica, 128, 319-324.
19. Salomon, F., Cueno, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body comparison and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-803.
20. Sobrinho, L.G. (1991) Neuropsychiatry of prolactin: cause and effects. Baillinre's Clinical Endocrinology and Metabolism, 5, 119-142.
21. Tordjman, K., Jaffe, A., Grazas, N., Apter, C. & Stern, N. (1995) The role of the low dose (1 μg) adrenocorticotropin test in the evaluation of patients with pituitary disease. Journal of Clinical Endocrinology and Metabolism, 80, 1301-1305.
22. Wallace, R.B., Sherman, B.M. & Bean, J.A. (1985) Clinical and biological antecedents of the amenorrhea/hyperprolactinaemia syndrome: a case control study. Fertility and Sterility, 43, 726-732.
23. Wang., D. Y., De Stavola, B.L., Bulhrook, R.D., Allen, D.S., Kwa, H.G., Verstraeten, A.A., Moore, J.W., Fentiman, I.S., Chaudary, M., Hayward, J.L. & Gravelle, I.H. (1987) The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. European Journal of Cancer and Clinical Oncology, 23, 1541-1548.
24. Weaver, J.U., Noonan, K., Kopelman, P.G. & Costa, M. (1990) Impaired prolactin secretion and body fat distribution in obesity. Clinical Endocrinology, 32, 641-646.